An IL12-IL2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation of NK and T cells for an Anti-Tumor Attack.

Autor: Jahn, Tobias1, Zuther, Martin1, Friedrichs, Björn1, Heuser, Claudia1, Guhlke, Stefan1, Abken, Hinrich1, Hombach, Andreas A.1 andreas.hombach@uk-koeln.de, Gray, Clive M.2
Zdroj: PLoS ONE. Sep2012, Vol. 7 Issue 9, Special section p1-13. 13p.
Databáze: Academic Search Ultimate